Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Vaccine efficacy of fusogenic liposomes containing tumor cell-lysate against murine B16BL6 melanoma
Immunotherapy for prostate cancer
Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96
Natural killer cells license dendritic cell cross-presentation of B lymphoma cell–associated antigens
Long-term outcomes in patients with metastatic melanoma vaccinated with melanoma peptide-pulsed CD34(+) progenitor-derived dendritic cells
Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma patients
Vaccine strategies to treat lymphoproliferative disorders
Harnessing the immune system against human glioma
Thermal regulation of lymphocyte trafficking: hot spots of the immune response
Virus-based therapies for colon cancer
Induction of anti-tumor immunity by vaccination with dendritic cells pulsed with anti-CD44 IgG opsonized tumor cells
Lentiviral vector expression of tumour antigens in dendritic cells as an immunotherapeutic strategy
Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells
Enhancement of antitumor immunity of dendritic cells pulsed with heat-treated tumor lysate in murine pancreatic cancer
Immunological treatment of liver tumors
Prostate cancer immunology: biology, therapeutics, and challenges
Dendritic cells pulsed with total tumor RNA for activation NK-like T cells against glioblastoma multiforme
Efficient stimulation of HIV-1-specific T cells using dendritic cells electroporated with mRNA encoding autologous HIV-1 Gag and Env proteins
Combined immunocell therapy using activated lymphocytes and monocyte-derived dendritic cells for malignant melanoma
Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity